Skye Bioscience, Inc. (SKYE)
Healthcare
Biotechnology
0.57 $
-2.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Skye Bioscience, Inc. (SKYE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -43 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.8 | -3.7 | -3.6 | -3.3 | -3.9 | -6.0 | -6.1 | -6.5 | -13 | -14 | -25 | -43 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.7 | |
| 0.0 | 0.4 | 0.7 | 0.6 | 0.7 | 0.7 | 0.3 | 0.9 | 0.6 | 1.0 | 8.3 | 7.8 | |
| – | – | -0.4 | 0.1 | 15 | -8.0 | -0.1 | 0.8 | – | – | – | – | |
| 0.5 | -0.4 | 0.0 | -0.3 | 0.1 | 0.3 | 0.1 | 0.6 | -0.8 | -0.5 | -2.6 | 4.7 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 1.6 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 5.2 | 6.6 | -0.2 | -20 | |
| – | – | 0.5 | 0.5 | 2.3 | 0.0 | 0.6 | 0.0 | -0.2 | 4.7 | 0.0 | – | |
| 2.0 | 6.7 | 0.4 | 3.5 | 5.5 | 6.0 | 6.7 | 13 | -0.2 | 16 | 84 | 0.0 | |
| 0.2 | 3.0 | -3.2 | 0.2 | 1.6 | 0.0 | 0.6 | 6.5 | -7.7 | 9.1 | 58 | -63 | |
| -1.8 | -3.7 | -3.6 | -3.3 | -3.9 | -6.0 | -6.1 | -6.6 | -13 | -14 | -27 | -43 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.